Anthony Fernando, the President and CEO of Asensus Surgical, expressed enthusiasm about the collaboration with Nagoya University Hospital, emphasizing,
The Senhance Surgical Robot System, tailored for pediatric surgery, brings a unique advantage with its specialized instrumentation and advanced clinical intelligence. Our proven success in various pediatric procedures in Europe and the U.S. fuels our eagerness to extend these benefits in Japan, setting a new standard with the first pediatric surgical robot in the country.
This is a notable milestone since it is the first pediatric surgical robot installation in Japan. According to the company, this remarkable accomplishment also marks the fourth global deployment of the Senhance system in 2023. This technology not only reduces invasiveness but also enhances precision, distinguishing it in its approach. The successful setting up of Asensus Surgical Inc.’s Senhance surgical robot at Nagoya University Hospital in Japan has been officially reported.
Senhance and LUNA are Developed by Asensus to Enhance Results.
- Asensus Surgical focuses on advancing healthcare outcomes through the development of Senhance and LUNA technologies.
- Senhance, designed for general laparoscopic and laparoscopic gynecological procedures, integrates machine vision, augmented intelligence, and deep-learning capabilities. The U.S. FDA granted clearance in 2017, and subsequent expansions, collaborations with Google and Nvidia, and global hospital placements have followed.
- Senhance achieved a significant milestone by becoming the first digital laparoscopic surgery system for pediatric use, receiving FDA clearance for this indication in March.
- Despite a previous recall due to “unintended movement,” Senhance is currently available in various regions, including the U.S., EU, Japan, Russia, and other countries.
- As part of its continuous innovation, Asensus introduced LUNA, a next-generation robot, building on the foundation of digital laparoscopy and the Senhance Surgical System.
- LUNA’s Intelligent Surgical Unit is specifically designed to enhance surgeon control and reduce surgical variability.
- As part of ongoing development, an in vivo lab evaluation of LUNA was recently conducted, showcasing the commitment to advancing surgical robotics technology.
Read More: EndoQuest Robotics Omnivision
Children’s-focused fourth deployment in Japan
Asensus Surgical achieves its fourth deployment in Japan, focusing on pediatric surgical applications.- Nagoya University Hospital becomes the latest site for the Senhance surgical system, marking a significant expansion for Asensus in the Japanese healthcare landscape.
- Over the past year, Asensus strategically placed Senhance Surgical Robot systems at Kashiwa and Kitakyushu General Hospital, showcasing a commitment to advancing surgical technology across the country.
- Saiseikai Shiga Hospital in Ritto, Japan, has also embraced the trend by agreeing to lease a Senhance surgical robot, contributing to the increasing adoption of advanced surgical robotics.
- Dr. Hiroo Uchida, from the Department of Pediatric Surgery at Nagoya University Hospital, emphasized the Senhance System’s value in pediatric surgery, citing its specialized design for smaller patients and the distinct advantage offered by reusable 3 mm instruments.
- Dr. Uchida further highlighted the adaptability of the system, praising its instinctive camera control, haptic feedback, and crucial safety features. The experience in laparoscopic surgery adds to the system’s appeal, making it a versatile and reliable choice for medical professionals.
- The deployment at Nagoya University Hospital is recognized not only for its clinical benefits but also for the economic value it brings. Dr. Uchida sees this as a significant step forward, aligning with the hospital’s goal of delivering the best care to young patients and establishing the Senhance System as the first pediatric surgical robot in Japan.
More About Senhance Surgical Robot System
Asensus Surgical (NYSE: ASXC) reports that Nagoya University Hospital in Japan has agreed to lease the Senhance surgical system, marking a significant milestone in the advancement of surgical technology.- The agreement, finalized at the end of December, signifies the first installation of a pediatric surgical robot system in Japan and the fourth global deployment for Asensus and Senhance in 2023.
- This move marks a notable expansion for Asensus in Japan, building upon previous installations at Kitakyushu General Hospital about a year ago and Kashiwa in December 2022. Saiseikai Shiga Hospital in Ritto, Japan, also joined the trend in September 2022 by agreeing to lease a surgical robot.
- Senhance, designed by Asensus for general laparoscopic and laparoscopic gynecological procedures, gained FDA clearance in 2017. Subsequently, the company secured expanded indications, formed collaborations with Google and Nvidia, and achieved widespread hospital placements globally.
- The Senhance system received recognition as the first and only digital laparoscopic surgery system for children when the FDA granted its pediatric indication in March.
- Dr. Hiroo Uchida, representing Nagoya’s pediatric surgery department, praised Senhance as a “valuable solution for pediatric surgery,” emphasizing its thoughtful design for smaller patients and the inclusion of reusable 3mm instruments.
- Uchida also highlighted Senhance’s intuitive camera control and haptic feedback, which incorporates crucial safety features, enhancing its appeal for pediatric surgical applications.
- Anthony Fernando, President and CEO of Asensus Surgical, expressed excitement about collaborating with Nagoya University Hospital, citing the Senhance Surgical Robot System’s specialized instrumentation and advanced clinical intelligence. He noted its unique advantage in pediatric surgery, reducing invasiveness and increasing precision, with a track record of success in Europe and the U.S. that they are eager to extend to Japan.
In Last of Senhance Surgical Robot System
In an integrated approach, Asensus Surgical incorporates machine vision, Augmented Intelligence, and deep learning capabilities throughout the entire surgical process.
Their main mission is to expansively tackle current clinical, cognitive, and economic challenges, causal to the advancement of value-based healthcare. With a promise to leverage state-of-the-art technologies, Asensus Surgical is dedicated to crafting a cohesive and advanced solution that propels the realm of surgery into a new and improved era, offering benefits to both patients and healthcare providers.
Asensus Surgical, Inc. stands at the lead of altering the dealings between surgeons and patients, indicating a transformative period known as Performance-Guided Surgery.
Their primary goal is to redefine the norms of surgical practices, empowering surgeons with advanced clinical intelligence for consistently higher results. Drawing from the foundational principles of Digital Laparoscopy and the Senhance Surgical System, the company is actively progressing the development of the LUNA™ Surgical System. Positioned as a cutting-edge robotic and instrument system, LUNA™ serves as the linchpin in Asensus Surgical’s Digital Surgery solution, fueled by the Intelligent Surgical Unit™ to optimize surgeon control and reduce surgical variability.
